Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3392-3399

  Viardot, Alexander ^a   Sze, Lisa ^b   Purtell, Louise ^a   Sainsbury, Amanda ^a   Loughnan, Georgina ^c   Smith, Ellie ^d   Herzog, Herbert ^a   Steinbeck, Katharine ^c,e   Campbell, Lesley V ^a,f  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CD11B ANTIGEN; CD14 ANTIGEN; CD3 ANTIGEN; CD66B PROTEIN; CD69 ANTIGEN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; L SELECTIN; LYMPHOCYTE ANTIGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN;

ABDOMINAL FAT; ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CD25+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MONOCYTE; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TONOMETER; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; COHORT ANALYSIS; IMMUNOLOGY; METABOLISM; PHOTON ABSORPTIOMETRY; PHYSIOLOGY;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADIPOSITY; ANTIGENS, CD; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INSULIN RESISTANCE; INTERLEUKIN-6; OBESITY; PRADER-WILLI SYNDROME;

EID: 77954915736     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2492     Document Type: Article

References (38)

1. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H 2001 Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 38:792-798 (Pubitemid 33032939)
2. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A, Bloom SR 2001 Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 86:4330-4338 (Pubitemid 32848555)
3. Talebizadeh Z, Butler MG 2005 Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet 67:230-239 (Pubitemid 40277903)
4. Caixàs A, Giménez-Palop O, Broch M, Vilardell C, Megía A, Simón I, Giménez-Pérez G, Mauricio D, Vendrell J, Richart C, González-Clemente JM 2008 Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects. J Endocrinol Invest 31:169-175
5. Patel S, Harmer JA, Loughnan G, Skilton MR, Steinbeck K, Celermajer DS 2007 Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clin Endocrinol (Oxf) 66:771-777 (Pubitemid 47024261)
6. Butler MG, Bittel DC, Kibiryeva N, Garg U 2006 C-Reactive protein levels in subjects with Prader-Willi syndrome and obesity. Genet Med 8:243-248 (Pubitemid 43756057)
7. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV 2004 Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109:3022-3028
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
9. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ 1996 Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638
10. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP 1993 An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 14:160-167
11. Cameron JD, McGrath BP, Dart AM 1998 Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension. J Am Coll Cardiol 32:1214-1220
12. Hayward CS, Kraidly M, Webb CM, Collins P 2002 Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol 40:521-528
13. Kelly R, Hayward C, Avolio A, O'Rourke M 1989 Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80:1652-1659
14. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ 2000 The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263-270
15. Greenfield JR, Samaras K, Hayward CS, Chisholm DJ, Campbell LV 2005 Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab 90:661-672
16. Goldstone AP, Brynes AE, Thomas EL, Bell JD, Frost G, Holland A, Ghatei MA, Bloom SR 2002 Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr 75:468-475
17. Marzullo P, Marcassa C, Campini R, Eleuteri E, Minocci A, Priano L, Temporelli P, Sartorio A, Vettor R, Liuzzi A, Grugni G 2005 The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome. J Clin Endocrinol Metab 90: 5639-5646
18. Cottam DR, Schaefer PA, Fahmy D, Shaftan GW, Angus LD 2002 The effect of obesity on neutrophil Fc receptors and adhesion molecules (CD16, CD11b, CD62L). Obes Surg 12:230-235
19. Stentz FB, Kitabchi AE 2005 Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun 335:491-495
20. van Oostrom AJ, van Wijk JP, Sijmonsma TP, Rabelink TJ, Castro Cabezas M 2004 Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth J Med 62:320-325
21. Haqq AM, Muehlbauer M, Svetkey LP, Newgard CB, Purnell JQ, Grambow SC, Freemark MS 2007 Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol (Oxf) 67:944-951
22. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG 2006 Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes (Lond) 30:382-387
23. Hoybye C, Bruun JM, Richelsen B, Flyvbjerg A, Frystyk J 2004 Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. Eur J Endocrinol 151:457-461
24. Ziemke F, Mantzoros CS 2010 Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91:258S-261S
25. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P 2004 Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110:1564-1571
26. Butler MG, Carlson MG, Schmidt DE, Feurer ID, Thompson T 2000 Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects. Am J Med Genet 95:67-70
27. Chorostowska-Wynimko J, Radomska D, Plywaczewski R, Jonczak L, Stepniewska A, Gorecka D, Skopinska-Rozewska E 2005 Disturbed angiogenic activity in sera from obstructive sleep apnea patients. J Physiol Pharmacol 56(Suppl 4):71-77
28. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M 2005 Increased carotid intimamedia thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625-630
29. Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K 2003 C-Reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 170:79-86
30. Kaushal K, Heald AH, Siddals KW, Sandhu MS, Dunger DB, Gibson JM, Wareham NJ 2004 The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome. Diabetes Care 27:2682-2688
31. Twickler TB, Dallinga-Thie GM, Visseren FL, de Vries WR, Erkelens DW, Koppeschaar HP 2003 Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration. J Clin Endocrinol Metab 88:1228-1233
32. Hána V, Prázný M, Marek J, Skrha J, Justová V 2002 Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement. Eur J Endocrinol 147:333-337
33. Soares DV, Spina LD, de Lima Oliveira Brasil RR, da Silva EM, Lobo PM, Salles E, Coeli CM, Conceição FL, Vaisman M 2005 Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement. Metabolism 54:321-329
34. Lanes R 2008 Endothelial dysfunction in growth hormone deficiency. J Pediatr Endocrinol Metab 21:319-321
35. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT 2003 Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 149:601-608
36. Sahoo T, del Gaudio D, German JR, Shinawi M, Peters SU, Person RE, Garnica A, Cheung SW, Beaudet AL 2008 Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 40:719-721
37. Wilson AG 2008 Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 79:1514-1519
38. Kreier F, Fliers E, Voshol PJ, Van Eden CG, Havekes LM, Kalsbeek A, Van Heijningen CL, Sluiter AA, Mettenleiter TC, Romijn JA, Sauerwein HP, Buijs RM 2002 Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J Clin Invest 110:1243-1250